ArticleJournal of cancer research and clinical oncology2023

Survival benefit and impact of adjuvant therapies following FOLFOX-HAIC-based conversion therapy with unresectable hepatocellular carcinoma: a retrospective cohort study.

Yangxun Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.